Vascular Technology

Vascular Technology

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

Vascular Technology, Inc. (VTI) is a privately held, commercial-stage medical device company focused on surgical support technologies. Its core offerings include a range of audio Doppler systems (1-20 MHz) for real-time intraoperative blood flow assessment and the Remotely Operated Suction Irrigation (ROSI) system for robotic surgery. With over 30 years of operational history (including predecessor entities), VTI serves a diverse global customer base in hospital operating rooms, leveraging an ISO 13485-certified and FDA-registered manufacturing facility. The company's strategy is built on product reliability, direct customer-driven innovation, and on-site support.

CardiovascularSurgical Support

Technology Platform

Intraoperative audio Doppler systems (1-20 MHz) for real-time blood flow detection and a Remotely Operated Suction Irrigation (ROSI) system for robotic surgery.

Opportunities

The growth of robotic surgery presents a key opportunity for VTI's ROSI system, allowing it to expand beyond its core Doppler business.
Additionally, an aging population and advancements in microsurgical techniques drive sustained demand for reliable intraoperative vascular monitoring tools.

Risk Factors

Key risks include competition from larger medical device companies, potential technological disruption of audio Doppler by advanced imaging modalities, and dependence on procedure volumes in specific surgical specialties which may shift over time.

Competitive Landscape

VTI competes in the niche surgical Doppler and suction/irrigation market against other specialized firms and larger medical device conglomerates. Its competitive edge is derived from product reliability, a focused product line for specific surgical needs, U.S. manufacturing, and direct customer service.